BIOJECT MEDICAL TECHNOLOGIES INC·4

Feb 1, 5:58 PM ET

Makar Ralph 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Feb 1, 2011

Insider Transaction Report

Form 4
Period: 2011-01-30
Makar Ralph
CEO/President
Transactions
  • Exercise/Conversion

    BJCT Common Stock

    2011-01-30+50,000877,368 total
  • Exercise/Conversion

    Restricted Stock Unit

    2011-01-3050,00050,000 total
    From: 2011-01-30BJCT Common Stock (50,000 underlying)
Holdings
  • BJCT Common Stock

    (indirect: By 401(k))
    142,322
Footnotes (3)
  • [F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
  • [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F3]No expiration date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT